Lawmakers: No Comment On Delegate's Medical Marijuana Roles
/ CBS Baltimore
ANNAPOLIS, Md. (AP) — Members of a Maryland legislative ethics panel aren't saying whether they have decided to hold a full investigation into a delegate who was a leading architect of the state's medical marijuana law. He is also a consultant for a company that is a finalist to grow and process the drug.
Several lawmakers on the General Assembly's Joint Committee on Legislative Ethics declined to comment after the nearly three-hour meeting Wednesday.
Sen. James DeGrange, who is the panel's co-chairman, told reporters after the meeting "everything is confidential."
Del. Dan Morhaim's role as a leading advocate for the law and his position as a consultant with Doctors Orders Maryland have raised questions in Annapolis. He said last month he followed ethics rules and regulations. He said he would cooperate with the committee.
We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.
Lawmakers: No Comment On Delegate's Medical Marijuana Roles
/ CBS Baltimore
ANNAPOLIS, Md. (AP) — Members of a Maryland legislative ethics panel aren't saying whether they have decided to hold a full investigation into a delegate who was a leading architect of the state's medical marijuana law. He is also a consultant for a company that is a finalist to grow and process the drug.
Several lawmakers on the General Assembly's Joint Committee on Legislative Ethics declined to comment after the nearly three-hour meeting Wednesday.
Sen. James DeGrange, who is the panel's co-chairman, told reporters after the meeting "everything is confidential."
Del. Dan Morhaim's role as a leading advocate for the law and his position as a consultant with Doctors Orders Maryland have raised questions in Annapolis. He said last month he followed ethics rules and regulations. He said he would cooperate with the committee.
In:- Medical Marijuana
More from CBS News